Dexcom leads the IQ 100
Dexcom leads the IQ 100 from CNBC.
Dexcom leads the IQ 100 from CNBC.
August 17th IQ 100 from CNBC.
IQ 100 August 14th from CNBC.
IQ 100 leaders include Seagate, Dexcom and Express Scripts. The laggards, Altaba, Micron and Baker Hughes.
IQ 100 August 9th from CNBC.
Today’s leaders include Express Scripts, DowDuPont and CBS. The laggards, Seagate, Booking Holdings and Deere.
IQ 100 July 30th from CNBC.
Today’s leaders include AT&T, Westrock and Hartford Financial. The laggard’s CBS, Bausch and Altaba. For more on the index go to CNBC.com/IQ100.
CNBC IQ 100 leaders, Avery Dennison, Deere and United Technology. The laggards include Whirpool, Halliburton and NCR.
CNBC IQ 100 leaders, Mattel, JP Morgan Chase and Bank of America. The laggards include, Halliburton, Illinois Tool and Micron.
Today’s IQ 100 leaders are Motorola Solutions, Dexcom and Visa. The laggards are Applied Materials, Micron and Seagate.
IQ100 index July 10th from CNBC.
Today’s leaders Micron, Texas Instruments and Dowdupont. Today’s laggards include Mattel, Kimberly-Clark, Callaway Golf.
The CNBC IQ100 Index powered by M·CAM has been reweighted for the third quarter of 2018. Microsoft (MSFT) becomes the IQ100’s highest-weighted component, while new component Boston Scientific (BSX) comes in at the second highest weight. These are companies that have demonstrated a superior ability to manage and deploy their innovation and intellectual property relative to their competitors.
The IQ100 outpaced gains in both the Dow Jones and the S&P 500 in the first half of 2018. Follow the index’s performance at CNBC.
The leaders, Praxir, Qualcomm and Xilinx. The laggards, Sony, Teva Pharma and Dexcom.
In commentary published today by CNBC, M·CAM chairman Dr. David Martin discusses the critical importance of innovation as a measure of market relevance. Last month’s replacement of GE by Walgreens Boots Alliance as a component of the Dow Jones Industrial Average was a big story, but the bigger story that was missed is what that change says about the shortcomings of the Dow itself.
To learn how M·CAM is actually measuring companies’ market-relevant innovation, visit the CNBC IQ100 Index powered by M·CAM at https://www.cnbc.com/iq100/ and follow its performance at https://www.cnbc.com/quotes/?symbol=IQ100
Index performance comparison chart courtesy of CNBC.
From M·CAM’s David Martin:
At the launch of Columbia University’s Earth Institute, I was honored to be invited to share M·CAM’s Global Innovation Commons water for the world platform by Constance Adams. Our shared journey since then impacted lives from New York to Mongolia, to India and across Africa. She was a great colleague and I’m honored to have shared this little blue ball with her for the season of her life. Travel well and my thoughts are with those still on this phase of the journey!
Read about Constance’s amazing life and work at National Geographic.
M·CAM chairman and CEO Dr. David Martin sat down with the hosts of CNBC’s Squawk Alley this morning to discuss GE’s biggest challenge going forward: managing the company’s strong portfolio of technologies for defense applications, particularly marine propulsion, and its most cutting-edge medical IP like diagnostic biochips. Despite its recent exit from the Dow, GE remains a constituent of the CNBC IQ 100 Index powered by M·CAM.
Watch the full conversation on CNBC.
IQ 100 June 19th from CNBC.
CNBC IQ 100 June 19th. Leaders include Dover Corp, Sonoco and IBM. Today’s laggards, Teradyne, Applied Materials and Bausch Health.
On June 12, 2018, M·CAM’s Dr. David Martin and Amusement Park Universe’s Jimmy Smith will participate in the Association of Independent Commercial Producers (AICP) Base Camp in New York City as part of the AICP Next Awards.
As the invited guests of the AICP Next Awards curators, the pair will take part in the Base Camp’s “Seven Minute Conversations” series in which they will discuss the future of the advertising industry with their conversation “True Innovation vs. Hype.”
Visit the AICP Next Awards here for more details about the 2018 curator sessions.
CNBC IQ 100 leaders, Teva Pharma, CBS Corp and Target. The laggards include Xerox, Mattel and Raytheon.